Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00547768 · ClinicalTrials.gov registry record · Phase 4
Comparative Study Evaluating the Effects of Fexofenadine HCI 180 mg With Orange Juice Versus Placebo With Orange Juice in a Skin Wheal and Flare Challenge Model.
A Phase 4 study, sponsored by Sanofi.
- Completed
- Registry status
- Phase 4
- Development phase
- 36
- Enrollment target
NCT00547768 is a Phase 4 study that has completed, run by Sanofi. The registered enrollment target is 36 participants.
The verdict
NCT00547768, a Phase 4 study, has completed, sponsored by Sanofi.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 36 participants
- Enrollment target
Study Summary
Compare the effect of a single dose of fexofenadine HCl 180 mg plus orange juice versus placebo plus orange juice on the change from baseline (pre-dose) in histamine skin flares.
Interventions
- DRUG Fexofenadine HCI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2002-11 |
| Est. Completion | 2002-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00547768
The ClinicalTrials.gov registry entry for NCT00547768 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanofi, which has 713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fexofenadine HCI is the first listed.
NCT00547768 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00547768 about?
NCT00547768 is a clinical study titled "Comparative Study Evaluating the Effects of Fexofenadine HCI 180 mg With Orange Juice Versus Placebo With Orange Juice in a Skin Wheal and Flare Challenge Model.". Compare the effect of a single dose of fexofenadine HCl 180 mg plus orange juice versus placebo plus orange juice on the change from baseline (pre-dose) in histamine skin flares.
What is the current status of trial NCT00547768?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 36 participants. The study started on 2002-11. Estimated completion is 2002-12.
What interventions are being tested in trial NCT00547768?
The interventions under investigation include: Fexofenadine HCI (DRUG).
Who is sponsoring clinical trial NCT00547768?
This trial is sponsored by Sanofi, which has 713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.